Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FG62F
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 16, 2025, by the Defense Logistics Agency for NUCALA 100 mg/mL auto-injector units. The contract is valued at $3,785.80 and represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award was issued without a set-aside designation, demonstrating the company's competitive standing in federal procurement. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, which carries a single-award vehicle valued at $499,999,999 through November 2026. The IDC enables the government to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. NUCALA, a specialty pharmaceutical auto-injector product, aligns with the company's established portfolio of delivering injectable medications and specialty treatments to military health systems, reinforcing its position as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FG62F?
SPE2DB25FG62F was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FG62F worth?
The government has obligated $3,786 on SPE2DB25FG62F.
Is contract SPE2DB25FG62F an order under another contract?
Yes. SPE2DB25FG62F is a delivery order under SPE2DB20D9157, an indefinite delivery contract.
Was contract SPE2DB25FG62F competed?
The extent of competition for SPE2DB25FG62F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award